← FDA Drug Approvals (Drugs@FDA)

CYCLOPHOSPHAMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LIMITED · Approved 2026-04-29

Drug application

FDA Application #

ANDA219271

Application type

Abbreviated New Drug Application (Generic)

Brand name

CYCLOPHOSPHAMIDE

Generic name

Cyclophosphamide

Active ingredients

CYCLOPHOSPHAMIDE

Dosage form

INJECTION

Route

SOLUTION

Marketing status

None (Tentative Approval)

Sponsor

HETERO LABS LIMITED

First approval

2026-04-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown